Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)	attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder	Recruiting	Phase 3	2026-09-08		NCT07717892

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Axsome Therapeutics, Inc.	14

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials